• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

Crinetics Pharmaceuticals

Anonymous board for Crinetics Pharmaceuticals
Replies
1
Views
2K
anonymous
Replies
0
Views
1K
anonymous